OpenAlex
PricingAboutJobs
Log inGet started
Work

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

HTML

Year: 2008
Type: article
Source: Journal of Pharmacology and Experimental Therapeutics
DOI: 10.1124/jpet.107.132910
Authors: C.J. Schmidt, D.S. Chapin, J. Cianfrogna, M.L. Corman, M. Hajos, J.F. Harms, W.E. Hoffman, L.A. Lebel, S.A. McCarthy, F.R. Nelson, C. Proulx-LaFrance, M.J. Majchrzak, A.D. Ramirez, K. Schmidt, P.A. Seymour, J.A. Siuciak, F.D. Tingley, R.D. Williams, P.R. Verhoest, F.S. Menniti
Institution: Pfizer (United States)
Language: English

Topic: Phosphodiesterase function and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PDE10A, PDE10A inhibitors, schizophrenia, papaverine, striatum, medium spiny neurons, cAMP signaling, cGMP signaling, basal ganglia, drug discovery, pharmacokinetics, selectivity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1969601547
FWCI: 6.604
Cites: 45
Cited by: 299
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms